Unison Asset Management LLC Purchases 256 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Unison Asset Management LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,547 shares of the healthcare conglomerate’s stock after purchasing an additional 256 shares during the quarter. UnitedHealth Group comprises approximately 5.8% of Unison Asset Management LLC’s investment portfolio, making the stock its 6th biggest position. Unison Asset Management LLC’s holdings in UnitedHealth Group were worth $10,085,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Fort Washington Investment Advisors Inc. OH grew its position in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after buying an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $515,000. Full Sail Capital LLC boosted its holdings in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $39,413,000. Finally, Silvercrest Asset Management Group LLC boosted its holdings in shares of UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after purchasing an additional 12,550 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.4%

Shares of UNH stock opened at $300.85 on Tuesday. The stock has a market capitalization of $272.91 billion, a price-to-earnings ratio of 12.60, a PEG ratio of 1.42 and a beta of 0.45. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company’s fifty day simple moving average is $353.44 and its two-hundred day simple moving average is $460.22. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the previous year, the company posted $6.91 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.94%. UnitedHealth Group’s payout ratio is 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Truist Financial reaffirmed a “buy” rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Barclays dropped their price target on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. Robert W. Baird lowered UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price for the company. in a research report on Wednesday, June 11th. Finally, Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $427.09.

Insider Buying and Selling

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director John H. Noseworthy purchased 300 shares of the business’s stock in a transaction on Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.